By expenditures
| Name | Title | Type |
|---|---|---|
| Ruchika Soin | Audit Manager | Auditee |
| Jeannette Kunz | Senior Manager | Auditee |
| Emily Bruening | Director - Finance | Auditee |
| Randy Koning | PARTNER | Auditee |
| Jill McCart | VP-ACCOUNTING | Auditee |
| Karthik Ramaswamy | Managing Director | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 392528 | 2025 | 2026-03-18 | ERNST & YOUNG LLP | $6.87M |
| 334184 | 2024 | 2024-12-20 | Ernst & Young LLP | $50.17M |
| 301777 | 2023 | 2024-04-01 | Ernst & Young LLP | $116.11M |
| 41573 | 2022 | 2023-03-30 | Ernst and Young LLP | $99.91M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 392528 | 2025 | 2026-03-18 | 1181238 | 2025-001 | Material Weakness | Yes | N |
| 392528 | 2025 | 2026-03-18 | 1181237 | 2025-001 | Material Weakness | Yes | N |
| 301777 | 2023 | 2024-04-01 | 967619 | 2023-004 | Significant Deficiency | - | L |
| 301777 | 2023 | 2024-04-01 | 967618 | 2023-003 | Material Weakness | - | ABN |
| 301777 | 2023 | 2024-04-01 | 967617 | 2023-004 | Significant Deficiency | - | L |
| 301777 | 2023 | 2024-04-01 | 967616 | 2023-003 | Material Weakness | - | ABN |
| 301777 | 2023 | 2024-04-01 | 967615 | 2023-004 | Significant Deficiency | - | L |
| 301777 | 2023 | 2024-04-01 | 967614 | 2023-003 | Material Weakness | - | ABN |
| 301777 | 2023 | 2024-04-01 | 967613 | 2023-004 | Significant Deficiency | - | L |
| 301777 | 2023 | 2024-04-01 | 967612 | 2023-003 | Material Weakness | - | ABN |
| 301777 | 2023 | 2024-04-01 | 967611 | 2023-002 | Significant Deficiency | - | L |
| 301777 | 2023 | 2024-04-01 | 967610 | 2023-001 | Material Weakness | - | A |
| 301777 | 2023 | 2024-04-01 | 391177 | 2023-004 | Significant Deficiency | - | L |
| 301777 | 2023 | 2024-04-01 | 391176 | 2023-003 | Material Weakness | - | ABN |
| 301777 | 2023 | 2024-04-01 | 391175 | 2023-004 | Significant Deficiency | - | L |
| 301777 | 2023 | 2024-04-01 | 391174 | 2023-003 | Material Weakness | - | ABN |
| 301777 | 2023 | 2024-04-01 | 391173 | 2023-004 | Significant Deficiency | - | L |
| 301777 | 2023 | 2024-04-01 | 391172 | 2023-003 | Material Weakness | - | ABN |
| 301777 | 2023 | 2024-04-01 | 391171 | 2023-004 | Significant Deficiency | - | L |
| 301777 | 2023 | 2024-04-01 | 391170 | 2023-003 | Material Weakness | - | ABN |
| 301777 | 2023 | 2024-04-01 | 391169 | 2023-002 | Significant Deficiency | - | L |
| 301777 | 2023 | 2024-04-01 | 391168 | 2023-001 | Material Weakness | - | A |
| 41573 | 2022 | 2023-03-30 | 622424 | 2022-002 | Significant Deficiency | - | L |
| 41573 | 2022 | 2023-03-30 | 622423 | 2022-001 | Material Weakness | Yes | AE |
| 41573 | 2022 | 2023-03-30 | 45982 | 2022-002 | Significant Deficiency | - | L |
| 41573 | 2022 | 2023-03-30 | 45981 | 2022-001 | Material Weakness | Yes | AE |